Loading company…
Reach Neuro develops an implantable device designed to help people with post-stroke paralysis regain arm and hand movement.
Founded in 2021 and based in Pennsylvania, US, Reach Neuro develops devices implanted in the spine to help people with post-stroke paralysis voluntarily control arm and hand movement. Its treatment is intended for use at home and during physical therapy. As of 2022, the company had begun first-in-human clinical trials. In December 2021, it raised seed funding from SOSV and received an NIH grant of over USD 8 million to continue clinical trials.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in